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Abstract 
The latest strategies and instrumental improvements for enhancing the detection 
sensitivity in chiral analysis by CE are reviewed in this work. Following the previous 
reviews by García-Ruiz et al. (Electrophoresis 2006, 27, 195-212) and Sánchez-
Hernández et al. (Electrophoresis 2008, 29, 237-251; Electrophoresis 2010, 31, 28-43), 
this review includes those papers that were published during the period from June 2009 
to May 2011. These works describe the use of off-line and on-line sample treatment 
techniques, on-line sample preconcentration techniques based on electrophoretic 
principles, and alternative detection systems to UV-Vis to increase the detection 
sensitivity. The application of the above-mentioned strategies, either alone or combined, 
to improve the sensitivity in the enantiomeric analysis of a broad range of samples, such 
as pharmaceutical, biological, food and environmental samples, enables to decrease the 
limits of detection up to 10
-12
 M. The use of microchips to achieve sensitive chiral 
separations is also discussed.  
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1. Introduction 
Enantioselective analytical techniques have been highly demanded in the last years 
due to the well-known relevance of chirality in the biological activity of compounds. 
Over the past decades, the use of capillary electromigration techniques, to carry out 
enantioselective separations of chiral compounds, has extensively been studied [1, 2]. 
Nowadays, there is no doubt that CE has evolved as an attractive and powerful 
separation technique providing high separation efficiency and short migration times, 
and needing low sample volumes. Thus, the latest advances of CE for the separation of 
chiral compounds in different fields, such as pharmaceutical industry, food science or 
environmental chemistry, among others, have been the subject of different reviews [3-
12].   
Different CE modes, such as EKC, MEKC, or ACE, and a huge variety of chiral 
selectors can be employed to achieve a chiral separation, making of CE a highly flexible 
technique. Among the different modes, EKC is without doubt the most used in the field 
of chiral separations. In the EKC mode, each enantiomer interacts in a different way 
with the chiral selector, so the enantiomeric discrimination is produced by a 
chromatographic mechanism [13-15]. 
In spite of the attractive properties of CE, it can hardly meet the requirements of 
trace or ultratrace analysis when using UV detection because of the small injection 
volume and short optical path length of on-column detection. For instance, the detection 
sensitivity of a commercial CE-UV system is one of the most serious limitations of CE, 
ranging the LODs from 10
-5
 to 10
-6
 M [12]. Thus, the development of strategies to 
obtain the detection sensitivity needed for a given application is usually required. In this 
regard, the approaches to enhance the sensitivity of CE, both in conventional and chiral 
analysis, have been focused on three different strategies such as (i) off-line and on-line 
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sample treatments, (ii) on-line sample preconcentratrion techniques based on 
electrophoretic or chromatographic principles, and (iii) the use of alternative detection 
systems to the UV/Vis detection [16-23]. Although in some cases the use of only one 
strategy is enough to improve the detection sensitivity, in other occasions the employ of 
a combination of strategies is necessary. Anyway, the combination of strategies is a 
current tendency since it can offer certain advantages to enhance the sensitivity as it will 
be deduced from the articles published in the period of time covered in this review. 
With the aim of providing to the readers an update on the latest strategies and 
instrumental improvements developed for enhancing the sensitivity in chiral analysis by 
CE, this review summarizes the literature published from June 2009 to May 2011 
showing the decrease in the detection limits up to 10
-12
 M, and serves as a continuation 
of the previous reviews on this topic published in 2006 [24], 2008 [25] and 2010 [26]. 
The potential of these strategies will be demonstrated on many application examples 
mainly aimed to the analysis of pharmaceutical, biological, food and environmental 
matrices. 
 
2. Approaches for improving the detection sensitivity 
Sensitivity is the critical point in the chiral analysis of real samples by CE. This 
explains why efforts to improve it are focused either on preconcentration techniques or 
on alternative detection systems. In this regard, the use of off-line and on-line sample 
treatment techniques, on-line sample preconcentration techniques and/or alternative 
detection systems to UV/Vis can significantly enhance both the analytical potential and 
the application range of chiral CE, because of they may solve its weakest points such as 
poor selectivity and high LOD. 
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Regarding the detection system, it is important to highlight that the combination 
of the partial filling technique (PFT) or the counter-migration technique (CMT) with 
chiral CE methodologies using UV or MS systems is often necessary to allow analyte 
detection. In PFT only a fraction of the capillary is filled with the buffer containing the 
chiral selector, while the rest of the capillary is filled with the buffer without the selector 
[27]. However, in CMT the capillary can be filled completely with BGE containing 
reverse-migrating chiral selectors since they migrate in the opposite direction to the 
detection system [28]. In both cases, the chiral selector never reaches the detector. Thus, 
this strategy is employed with the UV detector to avoid the presence of chiral selectors 
with a high UV absorption (e.g., in the case of selectors as macrocyclic antibiotics, such 
as vancomycin, which absorbs at low wavelengths, < 250 nm) in the detection cell, or in 
the case of MS detection to avoid the contamination of the ionization source by the 
chiral selectors that are usually non-volatile.   
Recent chiral approaches based on the above-mentioned strategies in which the 
LOD for enantiomers is at least 10
-6
 M will be described in the next sections.  
 
2.1 Off-line sample treatment techniques 
Sample pretreatment plays a key role in the analysis of complex samples in the 
performance of CE. Two of the most common procedures involved to obtain a high 
sensitivity and selectivity are sample preconcentration and chemical derivatization. The 
ideal sample preparation methodology should be fast, accurate, precise, and low solvent 
consuming. In addition, it should be easily adapted to the field of work and employ low 
cost materials. Table 1 shows the sample treatment techniques used for chiral analysis 
by CE-UV in the period of time covered by this review. Although liquid-liquid 
extraction (LLE) continues being the preferred off-line sample treatment, SPE is 
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demonstrating to be a powerful alternative, owing to its simplicity and economy in 
terms of analysis time and solvent. As it can be observed in Table 1, other treatments 
such as solid-liquid extraction (SLE), liquid phase micro-extraction (LPME), and 
derivatization have also been employed. 
 
2.1.1 Extraction techniques 
LLE is the most widely used sample treatment technique for clean-up and signal 
enhancement in routine analysis. This technique provides excellent sample clean-up for 
salts and biological macromolecules in spite of a broad range of other compounds may 
be co-extracted [38]. LLE has been employed for the extraction and concentration of 
drugs in culture media [29, 30] and biological samples [31] or alkaloids in herbs [32]. In 
addition, two chiral CE-UV methods, employing LLE and PFT, have been described in 
the period of time covered in this review to avoid the presence of amylose [31] or BSA 
[32] in the UV detector. Preconcentration factors between 3 [31] and 40 [29] and LODs 
up to 2 x 10
-8
 M were achieved.   
SPE shows a general applicability and can be very efficient yielding high 
preconcentration factors. This type of preconcentration prior to the CE separation can be 
performed off-line, at-line, in-line or on-line, being the first one the simplest way to 
combine SPE and CE [39]. Among these modes, only off-line SPE has been used in the 
chiral methodologies included in this review. This technique has been employed for the 
extraction and preconcentration of ibuprofen and its metabolites in biological samples 
using C18 SPE cartridges [33] and nicotine alkaloids in cigarettes using a strong anion 
exchange sorbent [34]. Concentration factors up to 10 [33] were achieved when the 
eluted samples were evaporated to dryness and the residues were redissolved in a 
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smaller volume of solvent in order to achieve higher preconcentration with LODs up to 
2 x 10
-7 
M.  
On the other hand, the SLE of some ergostane and lanostane compounds from 
Antrodia camphorata fungus was carried out using a soxhlet extractor [35]. After 
evaporating the solvent, the residue was subjected to silica gel column chromatography 
and eluted with increasing polarity mixtures of n-hexane/ethyl acetate. Then, the CE 
method provided efficient achiral and chiral separation of the compounds isolated in one 
single run achieving LODs up to 1x 10
-6
 M. 
 
2.1.2 Micro-extraction techniques 
Although LLE and SPE are the most widely employed extraction methods, they 
are time-consuming and need a large amount of organic solvents, which is hazardous for 
human health and the environment. To overcome these disadvantages, the miniaturized 
modification of the traditional extraction methods, such as solid-phase microextraction 
(SPME) or liquid-phase microextraction (LPME) has been carried out [40, 41]. 
Between them, LPME enables excellent sample clean-up effect, high extraction 
efficiency and lower cost than SPME.  
A mode of LPME named electro membrane extraction (EME) has recently been 
developed [42]. In this extraction procedure, the  liquid micro-extraction is based on the 
application of an electrical potential across supported liquid membranes (SLM) which 
is faster than conventional LPME in terms of kinetic (between 3 and 11 times) [36].  In 
this method, one of the electrodes is placed in the donor phase, whereas the other 
electrode is placed in the acceptor solution inside the lumen of the fiber (see Figure 
1A). Charged analytes in the donor phase migrated across the SLM towards the 
electrode of opposite charge in the acceptor solution. This implies that the analyte has to 
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be ionic in both acceptor and donor phases. EME has been proposed as sample 
treatment in the drug amlodipine determination by a chiral EKC-UV method [36]. The 
optimization of different extraction parameters such as organic solvent, time and 
voltage, pH in the acceptor solution and in the donor phase and stirring speed, was 
carried out. Figure 1B shows the electropherogram corresponding to the enantiomeric 
separation of amlodipine in spiked and drug-free human urine and plasma samples after 
EME. A preconcentration factor of 124 was obtained in 15 min of sample clean-up 
reaching LODs of 7 x 10
-9
 M for each enantiomer. 
 
2.1.3 Derivatization  
The derivatization procedure with a suitable reagent is performed with the 
purpose of increasing the detection sensitivity in CE converting the analyte into a 
different compound with new chemical properties [43]. In addition, other aspects such 
as the separation from interfering compounds, the electrophoretic behavior (namely, 
peak shapes or interaction with chiral selectors) or the prevention of decomposition 
during the analysis, can also be improved using a derivatization procedure.   
As it can be observed in Table 1, only one off-line derivatization method for 
chiral analysis of fenoprofen and six protein amino acids using FMOC as derivatization 
reagent has been described in the period of time covered in this review [37]. The 
derivatization reaction was carried out during 2 min at 25 ºC. Along with the 
derivatizacion process, another additional on-line sample preconcentration strategy 
(which will be described below) was also used. The combination of both procedures 
allowed to reach LODs at 10
-9
 M level. 
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2.2 On-line sample treatment techniques 
On-line sample treatments are attractive because they minimize the consumption 
of samples and reagents, reduce the operation cost and can improve the precision of the 
analyzed samples. However, in the period of time covered by this review there is only 
one work published for chiral analysis by CE with UV detection.  A single drop micro-
extraction (SDME) sample treatment was coupled to a chiral EKC-UV methodology for 
the analysis of primary amine compounds, amphetamine, p-chloroamphetamine and 2-
amino-1,2-diphenylethanol, in human urine samples [44]. SDME is a LPME mode in 
which the capillary inlet surface is covered with hydrophobic octadecyltrimethoxysilane 
and whose extraction steps are described in Figure 2A [45]. After injecting an octanol 
phase, the analytes of the sample solution (donor phase) are extracted into a single drop 
in an acidic buffer (acceptor phase) by applying backpressure from the outlet vial and 
covered by the octanol solvent (see image in Figure 2A). The optimum extraction by 
SDME was obtained in 10 min using higher concentration of the buffer acceptor phase 
for real samples than for standard samples in order to avoid a loss of extraction 
efficiency (see Figure 2B). The developed method allowed the separation of the six 
enantiomers around 35 min using (+)-(18-crown-6)-tetracarboxylic acid as a chiral 
selector with resolutions between 1.6 and 8.0. This hyphenation provided sensitive 
analysis yielding preconcentration factors from 400 to 1000-fold improvement in spiked 
urine samples and LODs between 2-10 x 10
-9
 M [44], which are much lower than the 
cutoff values of amphetamine test in the EU and USA.  
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2.3 On-line sample preconcentration techniques 
 
Among the three major approaches for enhancing sensitivity in CE, the 
application of on-line sample preconcentration techniques is the simplest, effective and 
cheapest [12]. The on-line preconcentration techniques used in EKC are mainly 
capillary ITP and sample stacking whereas sweeping is the most employed in MEKC. 
Detection sensitivity in CE can be further improved by combining two sample 
preconcentration techniques, for example, sweeping and stacking. During the period of 
time covered in this review, different strategies of stacking and sweeping have been 
described to increase the sensitivity in chiral CE-UV analysis, as it can be observed in 
Table 2. These strategies have usually been employed in combination with off-line 
sample treatment techniques. 
 
2.3.1 Stacking  
 
Stacking is based on the injection of a sample prepared in a matrix with a higher 
resistance, i.e, with minor conductivity, than the separation buffer [23, 47]. Thus, the 
analytes in the sample zone are stacked when they reach the boundary between the 
sample zone and the running buffer zone. Sample stacking techniques include normal 
sample stacking (NSS), large volume sample stacking (LVSS), field-amplified sample 
stacking (FASS), and anion- or cation-selective exhaustive injection (ASEI or CSEI). 
In NSS and LVSS the injection of the sample is hydrodynamic, being a larger injection 
in the case of LVSS, while an electrokinetic injection is used in FASS and ASEI or 
CSEI. A limitation in NSS is that the optimum sample plug length that can be injected 
into the capillary without loss of resolution is small (over 10% of the capillary length). 
However, a 1/3-1/2 of the capillary can be hydrodynamically filled with the sample 
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solution using LVSS, because in that case the sample matrix is pushed out of the 
capillary by the weak EOF prior to separation. When FASS, ASEI or CSEI are used to 
focus the analytes of the sample, there are no limitations in the injection volume.  
A highly sensitive strategy for the enantioseparation of fenoprofen and six 
FMOC-amino acids by EKC-UV using vancomycin (VC) as the chiral selector was 
developed by combining LVSS and ASEI [37]. The experimental schedule for this 
strategy is shown in Figure 3A. Before injection, the capillary (total length 39 cm) was 
fully filled with the buffer with VC. Large volume of sample (analyte anions dissolved 
in water) was thereafter hydrodynamically injected (34.45 mbar for 8 min) to leave a 
short plug of the background electrolyte (BGE) in the outlet end of the capillary (only 7 
cm). Then, stacking the analytes and removing the water plug by CMT using counter-
current EOF were achieved while additional analytes are selectively injected with 
electrokinetic injection by applying a voltage of -5 kV during 12.5 min. It should be 
noted that, the velocity of the anodic EOF must be lower than the cathodic velocity of 
the analytes to avoid them being pumped out of the capillary. Thus, a dynamically 
coating of the capillary with poly(N,N-dimethylacrylamide) was also carried out in 
order to almost suppress the EOF and to diminish the adsorption of VC onto the 
capillary wall. Electropherograms for enantioseparation obtained after on-line sample 
preconcentration by LVSS-ASEI are shown in Figure 3. The combination of all these 
strategies enabled to achieve a preconcentration factor of 1000-fold (compared with 
normal injection) and LODs as low as 2-21x 10
-9
 M. This method was successfully 
applied to the chiral separation of fenoprofen in a spiked river water sample.  
Borges et al. evaluated the possibility of using NSS and FASS as 
preconcentration techniques to study the biotransformation of different adrenergic 
agents in Czapek culture media (endophytic fungi) with a previous LLE [29, 30]. Thus, 
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NSS was performed using an injection of 50 mbar during 20 s for the chiral analysis of 
two β-adrenergic blocking agents (propranolol and its metabolite 4-hydroxypropranolol) 
[29]. Using carboxymethyl-β-CD as chiral selector, baseline separations were achieved 
within 16 min with LODs at 10
-7
 M level. This LOD enables the application of the 
developed method to study the enantioselective biotransformation of propranolol in its 
metabolite by the endophytic fungi after 72 h of incubation. A similar approach using 
FASS injection (10 kV during 5 s) has been used to study the biotransformation of 
midodrine and desglymidodrine (two -adrenergic agonists) in Czapek culture media 
[30]. In this work, the chiral separation of these compounds was obtained in 11 min, 
using (2,3,6-tri-O-methyl)-β-CD as chiral selector. Assuming that the studied analytes 
in both works are comparable, it could be affirmed that similar LODs (~10
-7
 M) can be 
achieved by NSS and FASS.   
 Finally, an ACE method with FASS preconcentration combined with PFT (to 
avoid BSA reaching the detector) was optimized and validated for the determination of 
tetrahydropalmatine enantiomers in herb samples [32]. The enantioresolution was 
achieved in less than 9 min and the LODs reported for each enantiomer were around 2 x 
10
-8
 M. 
 
2.3.2 Sweeping 
The sweeping mechanism is based on interactions between an additive in the 
separation buffer, which acts as a pseudostationary phase (usually micelles, CDs or 
complexing agents), and the sample [48, 49]. It enables an exceptional increase in the 
detection sensitivity for those analytes with a high solute pseudostationary phase 
association constant. Sample matrix may have different or the same conductivity than 
the separation buffer but it is very important that the sample matrix does not contain the 
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pseudostationary phase, since it is the component originating the preconcentration of the 
analyte by sweeping the sample matrix. 
Sweeping and stacking preconcentration techniques have been compared to 
enhance the detection sensitivity of three chiral triazole fungicides (hexaconazole, 
pentaconazole, myclotbutanil) by MEKC-UV using a CD as chiral selector [46]. The 
stacking was carried out by injecting the sample dissolved in water at 50 mbar during 10 
s, whereas sweeping strategy was achieved by dissolving the sample in buffer and 
injecting it during 70 s. Both methods allowed the separation of the six enantiomers 
within 15 min through a BGE of 2-hydroxypropyl-γ-CD and SDS in reverse polarity. 
The detection sensitivity of the three fungicides was increased from 9- to 10-times by 
stacking whereas sweeping enabled an increase from 62- to 67-times.  Besides, better 
LODs were achieved by sweeping (3-7 x 10
-7
 M) than by stacking (4-14 x 10
-6
 M). 
 
2.4 Detection techniques 
Chiral CE methods are usually carried out using on-column UV absorbance 
detection, even though its sensitivity is limited because of the short optical path length 
provided by the capillary diameter. This is a serious limitation especially in the analysis 
of samples containing low concentrations of enantiomers. For this reason, coupling of 
CE with alternative detection systems is of prime interest. During the period of time 
covered in this review, the number of publications employing alternative detection 
systems to the UV one, has increased compared with those reported in our previous 
review [26]. Thus, detection systems such as fluorescence, phosphorescence, 
electrochemiluminescence, conductivity and mass spectrometry have been coupled to 
CE for chiral analysis as it can be observed in Table 3.  
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2.4.1 Fluorescence 
The new developments in chiral analysis with CE describe the use of LIF 
detection through three different excitation sources: argon-ion laser [50-52], LED [53-
55] and deep-UV laser [56, 57]. LIF detection with argon-ion laser continues being one 
of the most used and most sensitive detection techniques in CE. However, nowadays the 
use of LED or deep-UV lasers as excitation sources has increased. Althought LED 
sources reduce the overall cost of the detector, the estimated LODs using this device are 
higher than those obtained under the same conditions using a LIF detector with argon-
ion laser. On the other hand, deep-UV lasers became an attractive source because of 
chemical derivatization is not necessary. Their main disadvantages are high costs and 
the specific requirements of their set-up.  
As it was discussed in the previous review [25, 26], the main application of CE 
with fluorescence detectors is the chiral analysis of amino acids. In the period of time 
reviewed in this article, the enantioseparation of amino acids has been achieved in 
different matrices such as standard samples [51, 56], pharmaceuticals [52], and 
biological samples [50, 53-55]. As it can be seen in Table 3, a previous derivatization 
of the amino acids with derivatizing agents such as FITC, 
dichlorotriazinylaminofluorescein (DTAF), naphthalene-2,3-dicarboxaldehyde (NAD) 
or cyanobenz[f]isoindole (CBI) was necessary in all the cases, except in those in which 
a deep-UV laser was employed as excitation source.  
In addition, some of the developed methodologies are combined with other off-
line [50] or on-line sample treatments [51], or other on-line sample preconcentration 
techniques [54-57] making possible to reach excellent LODs (up to 10
-12
 M), 
demonstrating that fluorescence is a powerful detection system for sensitive chiral 
analysis by CE. 
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An example of the combination of off-line treatment and LIF detection was 
shown by Li et al [50]. These authors combined an off-line microdialysis method of rat 
brain samples with CD-MEKC-LIF for the achiral and chiral determination of several 
compounds (seven protein amino acids, two non-protein amino acids, and O-
phosphoethanolamine) and serine, respectively. LODs ~10
-10
 M were achieved for each 
serine enantiomer allowing the study of the increase in the levels of the neuromodulator 
D-serine during cerebral ischemia/reperfusion. 
Regarding on-line strategies, a CD-MEKC-LIF methodology was combined with 
SDME (approach described in section 2.2) to preconcentrate four FITC-amino acids, 
namely leucine, alanine, glutamic acid and aspartic acid, from standard samples [51]. 
The chiral separation was performed in a short analysis time (16 min) using a dual 
chiral selector system with sodium taurodeoxycholate (STC) as chiral bile salt and β-
CD obtaining resolution values from 5 to 11. Preconcentration factors around 400-fold 
and LODs of 3-6 x 10
-11
 M were achieved using SDME during 10 min (see Figure 4A). 
Moreover, the additional use of a micro-stirrer during the extraction allowed to reach 
enrichments from 3000 to 6800-fold obtaining LODs of 1-3 x 10
-12
 M (See Figure 4B). 
As far as we know these are the lowest LODs achieved for chiral analysis of standard 
samples.  
On the other hand, Hsieh et al. carried out the determination of leucine, valine 
and isoleucine (derivatized with CBI) in human urine and plasma samples [54] and 
aspartic acid (derivatized with NAD) in cerebrospinal fluid, beer and soymilk samples 
[55] by MEKC-LIF (using LED as excitation source) combined with LVSS-sweeping. 
For the determination of CBI-amino acids, the employ of the LVSS, allowed an increase 
in sensitivity of 183-316 times, as it can be observed in the electropherograms a) and d) 
in Figure 5A. On the other hand, the use of LVSS in the determination of aspartic acid 
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provided an improvement of about 100-times (see Figure 5B). In both works, poly 
ethylene oxide (PEO) acted as a concentrated medium playing an important role in the 
stacking of enantiomers when 2-hydroxypropyl-β-CD was employed as chiral selector, 
allowing LODs of ~ 2 x 10
-10
 M. 
Finally, only two works about the use of deep UV as excitation source have been 
described in the period of time covered in this manuscript. In these works, a laboratory 
made miniaturized CE system (with only 10 cm of capillary), using FASS and deep 
UV-fluorescence, was applied to the determination of tryptophan [56] and propranolol 
[57] in standard samples. Analysis time comparable to those obtained in microchips 
(60-84 s) and LODs of 7 x 10
-11
 M and ~ 2 x 10
-10
 M for the enantiomeric determination 
of tryptophan and propranolol, respectively, were achieved.  
 
2.4.2 Phosphorescence 
An attractive detection technique in chiral CE in the last two years has been 
phosphorescence at room temperature in liquid deoxygenated solution. Three different 
modes can be distinguished, direct phosphorescence, where the phosphorescent analyte 
itself is excited by light of an appropriate wavelength, and two modes of indirect 
phosphorescence: sensitized and quenched. In the sensitized mode, the analyte is 
excited at its optimum excitation wavelength and transfers its energy to an acceptor 
(added to the BGE) from which phosphorescence is observed. In the quenched mode, 
strong phosphorophore compound (such as biacetyl or bromonaphthalene) is directly 
excited and its phosphorescence quantum yield is reduced by biomolecular quenching 
process with the analyte [69], which leads to negative peaks in the electropherogram. It 
should be noted that in this mode, non-phosphorescent analytes can be detected. It is 
also important to highlight that quenched phosphorescence is different from the indirect 
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UV absorption mode, which is based on electrophoretic displacement of the BGE by the 
analytes. 
Several works published by the Gooijer's research group have demonstrated the 
potential of phosphorescence as detection technique in sensitive chiral analysis.  In this 
works, LED [58], or Nd-YAG laser [59, 60] were employed as excitation sources using 
a sensitized phosphorescence mode. As shown in Table 3, different EKC methods 
coupled to phosphorescence detection were developed for the determination of 
camphorquinone [58, 59] and bupropion [60] in standards and different real samples. 
Under the optimal conditions in each case, LODs up to 4 x 10
-8
 M were reached. 
A comparison in terms of sensitivity between direct phosphorescence and 
sensitized phosphorescence modes, which were employed as detection systems for the 
determination of bupropion enantiomers, is depicted in Figure 6 [60]. As it can be 
observed in this figure, an improvement in the sensitivity of 40-times was achieved 
using the sensitized phosphorescence mode.  
 
2.4.3 Electrochemiluminescence 
CE coupled to Electrochemiluminescence (ECL) detection has extensively been 
employed in different fields of analytical chemistry. However, it has rarely been 
reported for chiral separations. In spite of the advantages in sensitivity and simplicity 
inherent to conventional chemiluminescence methods, one of the shortcomings of ECL 
assay is its poor selectivity [70].  
A CE-ECL methodology combined with LLE and FASS, as sample treatment 
and preconcentration technique, respectively, has been developed to carry out the chiral 
determination of dioxopromethazine in human urine samples [61]. Using β-CD as chiral 
selector, baseline resolution was obtained in only 13 min, reaching a LOD of 4 x 10
-6
 M 
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with 5 mM Ru(bpy)3
2+
 in 100 mM phosphate buffer (pH 8.0) as ECL solution in end-
column detection cell.   
 
2.4.4 Conductivity detectors 
CE with contactless conductivity detection (C
4
D) has progressed in the last years 
in terms of applications to different classes of analytes or approaches to the design of 
detectors [71]. The detection by C
4
D can be achieved both off-column and on-column. 
However, band broadening due to dead volume is avoided with on-column detection 
since the measurement is carried out directly inside the separation capillary.  In this 
detection system, it is not necessary to remove the protective coating from fused-silica 
capillaries and optically non-transparent polymeric tubings may also be employed. 
Recently, two CE-C
4
D methodologies have been developed for the chiral 
separation of protein amino acids and/or hydroxy acids [62, 63]. Thus, an EKC-C
4
D 
method has been developed for the enantioseparation of five -hydroxy acids and two 
-amino acids (aspartic acid and glutamic acid) using vancomycin as chiral selector 
[62]. Resolution values from 1.5 to 3.8 were obtained. The methodology developed in 
this work was applied to the determination of lactic acid enantiomers in samples of milk 
and yogurt, with LLE sample treatment prior to CE analysis, achieving LODs of 10
-6
 M 
for each enantiomer.  
On the other hand, an on-line preconcentration technique of transient moving 
chemical reaction boundary (tMCRB) by conductivity detection, with heart-cutting 
2D-CE was carried out for the chiral separation of DL-phenylalanine, and DL-threonine 
in a mixture of 22 amino acids [63]. The mechanism of focusing by tMCRB (see Figure 
7A) is based on a LVSS injection of solutes dissolved in basic medium (phase β) 
followed by their on-line focusing in the interface between the sample zone (phase β) 
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and the BGE zone (phase ). Then, a reaction of neutralization of the analytes occurs 
between the weak acidic zone (phase ) and the weak alkaline zone (phase β). The 
stacked fraction from the first dimension is isolated in the capillary, and separated in the 
second dimension by the presence of a chiral selector ((+)-(18-crown-6)-2,3,11,12-
tetracarboxylic acid) as it can be observed in Figure 7B.  The use of tMCRB 
preconcentration technique improved the LOD by a factor of 10 and 250 for 
phenylalanine and threonine, respectively. Figure 7C shows the enhancement of  
sensitivity of phenylalanine using different injection volumes in tMCRB. An injection 
volume of 10 % was selected as optimum since a higher volume would require the use 
of longer capillaries for keeping a sufficient electrophoretic separation increasing the 
total analysis time.  
 
2.4.5 MS   
One of the major breakthroughs of CE for the determination of chiral analytes in 
real matrices has been its online coupling to MS using ESI interfaces [21]. In fact, the 
hyphenation of chiral CE with MS is a powerful technique able to determine the 
enantiomers of chiral compounds with high selectivity and sensitivity. In addition, it is 
also able to solve the identification problems associated with unknown compounds in 
real samples since MS allows an unambiguous assignment of the different 
electrophoretic peaks and MS/MS spectra can also provide information about the 
structure of the analytes [20]. CE-MS is, along with CE-LIF, one of the most employed 
detection system for enhancing sensitivity in chiral CE by EKC [64-67] as it can be 
observed in Table 3.   
One of the main drawbacks of chiral analysis by CE-MS is the contamination of 
the ionization source by non-volatile chiral selectors. For this reason, the CE-MS 
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approaches developed in the last two years employ different strategies to avoid the 
contamination of the source. So, besides using the strategies of PFT [64, 65], the use of 
a very low concentration of chiral selector in EKC [66, 67], or a non ionizable chiral 
surfactant in MEKC [72] has been employed. Regarding MEKC mode, molecular 
micelles have a high weight allowing to have lower surface activity and volatility with 
essentially no background ions, which also enables to enhance the ESI-MS intensity. 
Thus, although the LOD was ~ 3 x 10
-5
 M, it was 3-5 times better than those obtained 
using UV detection.  
The enantioseparation of five chiral dipeptides in spiked serum samples was 
optimized by an EKC-ESI-MS methodology employing a PFT strategy [64]. Chiral 
separations with resolutions above 2.4 in 45 min were obtained, ranging the LODs 
obtained from 5 to 20 x 10
-8
 M. More recently, an EKC-ESI-MS/MS method with PFT 
was developed for the chiral separation of three neurotoxins derived from 1,2,3,4-
tetrahydroisoquinoline with the aim of investigating the in vitro formation of one of 
these neurotoxins, namely (R/S)-N-methylsalsolinol [65]. This work combines the 
strategies of PFT and CMT using an anionic CD (sulfated β-CD) as chiral selector, so 
that it migrated away from the MS ionization source during the separation, avoiding 
completely a possible contamination. Fast separations (less than 15 min), high 
resolutions (from 3.0 to 4.5) and enough sensitivity (LODs about 10
-6 
M level) were 
obtained.  
On the other hand, the direct introduction of the chiral selector at very low 
concentration has demonstrated to be a strategy that simplifies the PFT methodology 
without a significant contamination or loss in sensitivity [66, 67]. Following this idea, 
the enantioseparation of five protein amino acids by EKC-ESI-MS was carried out 
using a low quantity of modified β-CDs (0.5 mM) [66].  The sensitivity was only 3–5 
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times decreased by the chiral selector giving LODs of 2-19 x 10
-7
 M, which are higher 
than those obtained by a CE-LIF method developed under the same conditions (LODs 
from 4-9 x 10
-8
 M). The usefulness of the chiral CE-MS method was demonstrated 
through the detection of the main D- and L-amino acids found in different real samples 
including transgenic versus wild soy and vinegar. The same strategy was applied for the 
enantioseparation of the non-protein amino acid carnitine by EKC-ESI-MS
2
 [67]. A 
concentration of only 0.2% (w/v) of succinyl-γ-CD was used to carry out the 
enantioseparation.  Resolution about 3 and a LOD of 6 x 10
-8
 M were obtained, which 
was enough to detect enantiomeric impurities up to 0.002% of D-carnitine with respect 
to the main enantiomer (L-carnitine) in pharmaceuticals. Figure 8 shows the 
enantioseparation of carnitine in a pharmaceutical formulation in which the lowest 
percentage of D-carnitine (0.6 %) out of all the samples analyzed, was detected.  
In the last two above-described methodologies, the amino acids studied were 
labeled with FITC [66] or FMOC [67]. This fact is because of although MS does not 
imply derivatization strategies, for small molecules such as amino acids, the increase in 
their sizes allows an improvement in the sensitivity because they appear in a higher 
range of m/z where the S/N is lower.  
Finally, the coupling CE-ICP-MS has been employed, for the first time, for the 
development of a chiral methodology for the separation of the enantiomers of the 
hormone thyroxine in pharmaceuticals [68]. The method was based on ligand-exchange 
mechanism using a Cu(II)/L-proline complex as chiral selector and the monitoring of 
iodine (
127
I) as specific detection. The chiral separation was achieved in less than 15 
min with a resolution around 4 and the LODs obtained (~ 4 x 10
-7
) were similar to those 
reached by conventional UV detection.  
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3. Microchips   
Chiral microchip CE is gaining popularity due to the development of simple 
micro-fabrication methods [73]. The high electric fields in combination with the short 
separation lengths can produce analysis times of seconds. However, microchip CE also 
suffers from low sensitivity for similar reasons as in conventional CE and very few 
works have been reported using UV detection. For instance, using a microchip EKC-
UV method for the enantioseparation of the drug naproxen employing methyl-β-CD as 
chiral selector, the LOD was 10
-5
 M which is 2.5 times lower that the LOD obtained, 
under similar conditions, by conventional EKC-UV [74]. Nevertheless, the separation of 
(R,S)-naproxen by microchip CE was achieved in just 20 s with better resolution and 
similar precision than EKC-UV, showing the potential of this device. 
The trend in chiral microchip electrophoresis, as in conventional chiral CE, is 
the combination of different strategies to improve the sensitivity in order to carry out its 
application in the analysis of real samples, which have had little attention up to now. 
Thus, Huang et al. [75] have developed a microchip MEKC-LIF methodology for the 
chiral separation of tyrosine previously derivatized with FITC. The enantioresolution 
was obtained in around 2 min with a LOD of 3 x 10
-8 
M which allowed the 
determination of D-tyrosine in human plasma samples previously extracted by LLE.  
 
4. Concluding remarks  
This review article summarizes the developments reported to enhance the 
sensitivity in enantioseparations by CE in the last two years and their main applications. 
CE offers a very high flexibility for enantiomeric separations, due to the wide variety of 
chiral selectors that can be used into the CE systems and the different working modes 
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that can be employed. EKC and MEKC were the most employed modes to achieve 
enantioseparations by CE although ACE has also been employed. 
CE needs of powerful strategies to increase the limited sensitivity of 
detection achieved in enantioseparations. Thus, techniques based on effective off-line 
and on-line sample pretreatment offer enhanced sensitivity and selectivity. In addition, 
the development of micro-extraction techniques allows faster and cheaper procedures 
than the conventional ones in terms of solvent and preconcentration factor. In this 
regards, enrichments up to 6800-fold have been achieved. 
Among the on-line capillary preconcentration techniques, stacking has 
predominated because of its relative simplicity compared to other procedures such as 
sweeping, achieving significant improvements in sensitivity when a combination of two 
sample preconcentration techniques are used, for example, LVSS and ASEI, for which 
the best LODs was obtained (up to 2 x 10
-9
 M).  
However, it is clear that the major trend in the last two years has been the use of 
chiral CE methodologies using alternative and more sensitive detection methods than 
UV detection, mainly LIF or MS detection. It should be noted that, combinations of 
these kind of detectors with other strategies to increase the sensitivity such as, off-line 
sample treatment techniques and on-line preconcentration techniques, especially 
combinations of two or more of them, is expected to have greater impact on the future 
work because LODs up to 10
-12
 M have been achieved.  
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Figure captions 
 
Figure 1. (A) Schematic illustration of the setup for EME. (B) Electropherograms 
obtained after EME from spiked with amlodipine and drug-free human urine and 
plasma (spiked sample solution: 50 ng/mL of each enantiomer). Extraction conditions: 
HCl 10 mM as the acceptor and donor phases, 200 V voltage, 1000 rpm stirring rate, 
SLM: nitrophenyl octylether. Electrophoretic conditions: fused silica capillary, 60 cm 
total length (50 cm effective length) and 75 µm id; BGE, 100 mM phosphate buffer (pH 
2.0) containing 5 mM HP- -CD; applied voltage, +20 kV; temperature, 25ºC; injection, 
60 mbar for 5 s; UV detection, 214 nm. Peaks, R-amlodipine and S-amlodipine. 
Reprinted from [36] with permission. Copyright Wiley-VCH Verlag BmbH KGaA. 
 
Figure 2. (A) Procedure of SDME-CE: (1) Injection of the organic phase (octanol), (2) 
2-phase drop formation by ejection of the organic phase (include the image of a 2-layer 
drop formation), (3) extraction of the sample in the donor phase into the acceptor phase, 
and (4) injection of the enriched acceptor phase into the capillary for CE chiral 
separation (reprinted from [45]. Copyright (2009), with permission from ACS); (B) 
Comparison of the electropherograms for the buffer acceptor concentration in urine 
sample enriched by 10 min SDME: (a) standard solution (pH 13.7) to the acceptor phase 
of 50 mM Bis-Tris/CA (pH 4.0), (b) urine (pH 13.7) to 50 mM Bis-Tris/CA (pH 4.0), 
and (c) urine (pH 13.7) to 120 mM Bis-Tris/CA (pH 4.0). Electrophoretic conditions: 
fused silica capillary, 60 cm total length (50 cm effective length) and 50 µm id; BGE, 
50 mM Bis-Tris/CA containing 0.8 mM 18C6H4 (pH 4.0); applied voltage, +25 kV; 
temperature, 25ºC; injection, 0.3 psi for 5 s; UV detection, 200 nm. Peaks: (1) 500 nM 
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amphetamine, (2) 200 nM p-chloroamphetamine, (3) 600 nM 2-amino-1,2- 
diphenylethanol, (*) creatinine. Reprinted from [44] with permission. Copyright Wiley-
VCH Verlag BmbH KGaA. 
Figure 3. (A) Schematic representation for LVSS-ASEI and enantioseparation: (i) 
filling the capillary with the buffer containing vancomycin (); (ii) hydrodynamic 
injection of the sample by pressure; (iii) stacking the sample and removing the water 
plug by EOF and injection of more sample by ASEI; (iv) enantioseparation.  (B) and 
(C) Electropherograms for enantioseparation of FMOC-Ala, fenoprofen (Feno) and 
other FMOC-amino acids after sample concentration with LVSS-ASEI. Conditions: 
fused silica capillary, 50 µm id × 39 cm (29 cm to detection window); BGE used for 
filling the capillary before injection, 100 mM Tris–H3PO4 (pH 6.0) containing 2 
mmol/L vancomycin; BGE used for separation, 100 mM Tris–H3PO4 (pH 6.0); samples 
was injected by pressure at 34.47 mbar for 8 min, followed by electrokinetic injection 
by applying voltage of −5 kV for 12.5 min; detection wavelength, 214 nm; column 
temperature, 20ºC; applied voltage for separation, −15 kV. Concentrations for each 
enantiomer: fenoprofen (Feno), 2.5 ng/mL, and all FMOC-amino acids, 13.5 ng/mL. 
Adapted from [37]. Copyright (2011), with permission from Elsevier. 
 
Figure 4. (A) Electropherograms of FITC-AAs (a) 250 nM without SDME (b) 2.5 nM 
enriched by 10 min SDME. (B) Electropherograms of 2.5 nM FITC-AAs (a) enriched 
by 10 min SDME without stirring, and (b) enriched by 10 min SDME with stirring. 
Electrophoretic conditions: fused silica capillary, 60 cm total length (50 cm effective 
length) and 25 µm id; BGE, 80 mM borate (pH 9.3) + 12 mM  β-CD + 8 mM STC; 
applied voltage, +25 kV; temperature, 25ºC; injection, 0.3 psi for 2 s; LIF detection, 488 
 32  
 
and 520 nm (excitation and emission wavelengths). Peaks: 1. D-Leu, 2. L-Leu, 3. D-
Ala, 4. L-Ala, 5, D-Glu, 6. D-Asp, 7. L-Glu, 8. L-Asp. Reprinted from [51]. Copyright 
(2010), with permission from Elsevier. 
 
Figure 5. (A) Electropherograms of 0.1 µM CBI-DL-amino acids by on-line 
preconcentration when the sample was hydrodynamic injected at 20-cm height for (a) 3 
s, (b) 90 s (c) 120 s and (d) 180 s. Electrophoretic conditions: fused silica capillary, 50 
cm total length (40 cm effective length) and 75 µm id; Before separation, the capillary 
was filled with a solution of 100 mM tris-borate, 50 mM HP-β-CD, and 150 mM SDS, 
whereas buffer vials contain 0.5% w/v PEO, 20 mM tris-borate, 150 mM SDS, and 50 
mM HP-β-CD; applied voltage, +10 kV; temperature, 25ºC; LIF detection, 410 nm 
(excitation wavelength). Peaks: 1. D-Val; 2. L-Val; 3. D-Ile; 4. D-Ile; 5. D-Leu; 6. L-
Leu. Reprinted from [54] with permission. Copyright Wiley-VCH Verlag BmbH 
KGaA. (B) Electropherograms of 0.1 µM NAD-DL-Asp enantiomers by on-line 
preconcentration when were hydrodynamic injected (a) 25 nL, (b) 150 nL, (c) 300 nL, 
and (d) 600 nL of the sample. Electrophoretic conditions: fused silica capillary, 60 cm 
total length (50 cm effective length) and 75 µm id; Before separation, the capillary was 
filled with a solution of 150 mM tris-borate, 60 mM HP-β-CD, and 150 mM SDS, 
whereas buffer vials contain 0.6% w/v PEO, 150 mM tris-borate, 150 mM SDS, and 60 
mM HP-β-CD; applied voltage, +8 kV; temperature, 25ºC; LIF detection, 410 nm 
(excitation wavelength). Peaks: 1. D-Val, 2. L-Val. Reprinted from [55]. Copyright 
(2010), with permission from Elsevier. 
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Figure 6. Electropherograms showing the separation of bupropion enantiomers (1.5 x 
10
-5
 M each) using direct (A) or sensitized indirect (B) phosphorescence modes. The 
decays for the enantiomers at the electrophoretic peak maxima for both detection modes 
are also shown. Electrophoretic conditions: fused silica capillary, 90 cm total length (50 
cm effective length) and 75 µm id; BGE, without biacetyl (A) or with 2 x 10
-4
 M 
biacetyl (B) with 5 mM sulfated- -CD in 25mM phosphate (pH 3.0); applied voltage,    
-20 kV; temperature, 20ºC; injection, 50 mbar for 0.16 min; Phosphorescence detection, 
266 nm (excitation wavelengths); neutral density filter, 3%; cut-off filter, 300 nm; band 
pass filter, (A) 415–585 or (B) 490–600 nm. The BGE was purged with nitrogen to 
remove oxygen. Reprinted from [60] with permission. Copyright Wiley-VCH Verlag 
BmbH KGaA. 
 
Figure 7. (A) Mechanism of focusing by tMCRB. (a) Injection of analytes (anionic) 
diluted in alkaline phase (ammonium formate, phase β) by hydrodynamic pressure. The 
electrolyte of separation is acidic (phase ). (b) Formation of β boundary where the 
analytes stack by application of a voltage. It symbolized the reaction of neutralization 
between weak acidic phase consisting of acetic acid (H+) and weak alkaline phase 
consisting of ammonium formate (OH
-). Analytes are anionic in phase β and cationic in 
phase . (B) Principle of the on-line tMCRB preconcentration combined with heart-
cutting 2D-CE for the achiral (first dimension) and chiral separation (second dimension) 
of complex mixtures in a single capillary: (1) Hydrodynamic injection of the sample 
diluted in alkaline phase for tMCRB preconcentration; (2) Achiral separation of stacked 
amino acids and evacuation of fraction A in the first dimension; (3) Introduction of the 
second dimension electrolyte (BGE 2) by hydrodynamic flow; (4) Isolation of fraction 
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B in the capillary after evacuation of fraction C by the inlet end of the capillary; (5) 
chiral resolution of the fraction B in the second dimension of the separation. (C) 
Electropherograms showing the on-line focusing by tMCRB in non-chiral CE 
separation of a mixture containing 22 native amino acids at 1 mM of each enantiomer 
for different hydrodynamic injection volumes: 50 psi for 0.4 min (5% of the total 
capillary volume); for 0.8 min (10%); for 1.2 min (15%,), for 1.6 min (20%). 
Electrophoretic conditions: fused silica capillary, 60 cm total length (46.6 cm effective 
length) and 10 µm id; BGE, 2.3 M acetic acid; applied voltage, +30 kV; temperature, 
25ºC; Conductivity detection. Peak F, DL-Phe. Reprinted from [63] with permission. 
Copyright Wiley-VCH Verlag BmbH KGaA. 
 
Figure 8. CE-ESI-MS
2
 EIE for a pharmaceutical sample and the corresponding MS
2
 
spectra for the peaks of L- and D-carnitine. Electrophoretic conditions: fused silica 
capillary, 100 cm total length and 50 µm id; BGE, 0.5 M ammonium formate (pH 2.5) 
with 0.2% (m/v) succ-γ-CD; applied voltage, +25 kV; temperature, 25ºC; injection by 
pressure at 50 mbar×12 s. ESI conditions: positive ion mode; spray voltage, 4.5 kV; 
sheath liquid, isopropanol/water (50/50 v/v) with 0.1% formic acid at 3.3 µL/min; 
drying gas flow, 5 L/min; drying temperature, 300 ◦C; nebulizer pressure, 2 psi; 
compound stability, 50%. MS
2
 transitions, 384→179 m/z; width, 4 m/z; fragmentation 
amplitude, 1.20 V. Reprinted from [67]. Copyright (2010), with permission from 
Elsevier. 
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Table 1. Off-line sample treatment techniques employed for the enhancement of the sensitivity in chiral analysis by CE-UV. 
 
Sample 
treatment 
CE mode 
(λ detection) 
Chiral analyte Sample BGE LOD (M) Ref. 
      
LLE EKC 
(208 nm) 
Propranolol, 4-hydroxypropranolol Czapek culture 
medium 
 
25 mM triethylamine/phosphoric acid (pH 9.0) 
+ 4% (w/v) CM-β-CD 
~ 1 x 10
-7
 29 
LLE EKC 
(200 nm) 
Midodrine, desglymidodrine Czapek culture 
medium 
 
70 mM acetate (pH 5.0)  
+ 30 mM TM-β-CD 
~ 1 x 10
-7
 30 
LLE EKC 
(214 nm) 
Trihexyphenidyl, primaquine, 
Sulconazole, cetirizine 
Rabbit blood 
 
20 mM phosphate in water (pH 3.0) 
PFT: 20 mM phosphate in DMSO/water (40/60, 
v/v) (pH 3.0) + 10% (w/v) amylose (2 psi x 240 s) 
~ 3 x 10
-7
 31 
LLE ACE 
(200 nm) 
Tetrahydropalmatine 
 
Herbs 20 mM phosphate (pH 7.4) 
PFT: 50 µM BSA (50 mbar x 100s) 
~ 2 x 10
-8
 32 
SPE EKC 
(220 nm) 
Ibuprofen, (R,S)-29-
hydroxyibuprofen, (RR,RS,SR,SS)-
29-carboxyibuprofen 
Human Urine 20 mM triethanoloamine/phosphoric acid (pH 5.0) 
+ 50 mM TM-β-CD 
~ (2-24) x 10
-7
 33 
SPE EKC 
(260 nm) 
Nicotine, cotinine, nornicotine, 
anatabine, anabasine 
Cigarettes 30 mM acetate (pH 5.0)  
+ 8% (w/v) S-β-CD 
~ (9-20) x 10
-7
 34 
SLE EKC 
(243 nm) 
Methyl antcinate B, Antcin B, 
Zhankuic acid C, Antcin A, Antcin C 
Antrodia 
camphorata 
fungus 
20 mM borate (pH 9.3) + 5 % DMF  
+ 20 mM M-β-CD + 30 mM SB-β-CD  
~ (1-9) x 10
-6
 35 
LPME EKC 
(214 nm) 
Amlodipine Plasma and 
human urine 
100 mM phosphate (pH 2.0)  
+ 5 mM HP- -CD 
~ 7 x 10
-9
 36 
Derivatization 
with FMOC 
EKC 
(214 nm) 
Fenoprofen, 
Ala, Leu, Met, Phe, Ser, Val 
River water 100 mM Tris–phosphate (pH 6.0)  
+ 2 mM vancomycin 
~ (2-21) x 10
-9
 37 
 
Ala, Alanine; Arg, arginine; Asn, asparagine; Asp, aspartic acid; CM-β-CD, carboxymethyl-β-CD; DNS, dansyl; His, histidine; HP- -CD: 2-hydroxypropyl- -CD; HP-γ-
CD, 2-hydroxypropyl-γ-CD; Ile, isoleucine; Leu, leucine; Lys, lysine; M-β-CD,  methyl-β-CD; MeOH, methanol; Met, methionine; Phe, phenylalanine; S-β-CD, sulphated-
β-CD; SB-β-CD, sulfobutylether-β-CD; Ser, serine; Thr, Threonine; TM-β-CD, heptakis (2, 3, 6-tri-O-methyl)-β-CD;; Trp, tryptophan; Tyr, tyrosine; Val, valine. 
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Table 2. On-line sample preconcentration techniques employed to enhance the sensitivity in chiral analysis by CE-UV. 
 
 
Concentration 
strategy 
CE mode 
(λ detection) 
Analyte Sample BGE Injection conditions LOD (M) Ref. 
        
LVSS-ASEI EKC  
(214 nm) 
Fenoprofen, Ala, Leu, 
Met, Phe, Ser, Val 
River water 100 mM Tris– phosphoric acid (pH 6.0)  
+ 2 mM vancomycin 
Injection: 34.45 mbar x 8 min, 
and -5 kV x 12.5 min 
Sample solvent: H2O 
(2-21) x 10
-9
 37 
NSM EKC 
(208 nm) 
Propranolol,  
4-hydroxypropranolol 
Czapek 
culture 
medium 
25 mM triethylamine/phosphoric acid (pH 9.0) 
+ 4% (w/v) CM-β-CD 
Injection: 50 mbar x 20 s 
Sample solvent: 1/10 buffer 
~ 10
-7
 29 
FASS EKC 
(200 nm) 
Midodrine, 
desglymidodrine 
Czapek 
culture 
medium 
70 mM acetate (pH 5.0)  
+ 30 mM TM-β-CD 
Injection: 10 kV x 5 s, and 
water plug: 35 mbar x 5 s 
Sample solvent: H2O/MeOH 
(10/90 v/v) 
~ 10
-7
 30 
FASS ACE 
(200 nm) 
Tetrahydropalmatine Corydalis 
yanhusuo herb 
20 mM phosphate (pH 7.4)  
PFT: 50 µM BSA (50 mbar x 100s) 
Injection: 15 kV x 12 s, and  
water plug: 25 mbar x 8 s 
Sample solvent: H2O; 
  
~ 2 x 10
-8
 32 
Sweeping MEKC 
(200 nm) 
Hexaconazole, 
pentaconazole, 
myclotbutanil 
Standards 25 mM phosphate (pH 3.0) + 50 mM SDS 
 + 40 mM HP-γ-CD  
Injection: 50 mbar x 70 s 
Sample solvent: buffer 
without SDS and CD 
(3-7) x 10
-7
 46 
 
 
Ala, Alanine; CM-β-CD, carboxylmethyl-β-CD; HP-γ-CD, 2-hydroxypropyl-γ-CD; Leu, leucine; MeOH, methanol; Met, methionine; Phe, 
phenylalanine; Ser, serine; TM-β-CD, heptakis (2, 3, 6-tri-O-methyl)-β-CD; Val, valine. 
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Table 3. Alternative detection systems to UV detector, with or without other strategies, to improve sensitivity detection in chiral analysis by CE. 
 
Detection System Other strategies 
CE 
mode 
Analyte Sample BGE LOD (M) Ref. 
        
LIF 
(λexc = 488 nm) 
FITC 
derivatization  
+ off-line 
microdialysis 
MEKC Ser Extracellular fluid 
of rat hypothalamus 
15 mM borate (pH 10.2) + 70 mM SDS  
+ 5% (v/v) MeOH 
+ 17.5 mM HP-β-CD + 5 mM DM-β-CD 
 
~ 1 x 10
-10
 50 
LIF 
(λexc= 488 nm,  
λem= 520 nm) 
FITC 
derivatization 
 + on-line SDME 
MEKC Ala, Asp,  
Glu, Leu, 
Standards 
 
80 mM borate  (pH 9.3)  
+ 8 mM STC + 12 mM  β-CD  
 
(1-3) x 10
-12
 
 
51 
 
LIF  
( λexc = 488 nm,  
λem = 520 mm) 
DTAF-
derivatization 
MEKC Asp Pharmaceuticals 8 mM borate (pH 8.9) + 10% (v/v) MeOH  
+12 mM SC + 0.8% (w/v) HSA  
3 x 10
-10
 
 
52 
 
LIF  
( λexc = 488 nm,  
λem = 520 mm) 
DTAF-
derivatization 
MEKC Glu Pharmaceuticals 10 mM borate (pH 9.1) + 5% (v/v) MeOH  
+ 12 mM SC + 1.6 % (w/v) HSA  
1 x 10
-10
 
 
52 
 
LIF  
(λexc = 475 nm) 
FITC 
derivatization 
MEKC Ser Midbrain of a 
Parkinson's disease 
mouse 
 
25 mM borate  (pH 9.5) + 50 mM SDS 
+ 10 mM γ-CD 
~ 2 x 10
-8
 53 
LIF  
(λexc = 410 nm) 
CBI derivatization 
+ LVSS-sweeping 
MEKC Leu, Ile, Val Human urine and 
plasma 
100 mM tris-borate (pH 9.0) + 150 mM SDS 
+ 50 mM HP-β-CD 
~ 2 x 10
-10
 54 
 
LIF  
(λexc = 410 nm) 
NAD 
derivatization  
+ LVSS-sweeping 
MEKC Asp Cerebrospinal fluid, 
soymilk, beer 
 
150 mM tris-borate (pH 9.0) + 150 mM SDS 
+ 60 mM HP-β-CD 
~ 2 x 10
-10
 55 
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LIF 
(λexc= 280 nm, 
em= 266 nm) 
FASS EKC Trp Standards 1 mM phosphate (pH 2.5)  
+ 0.15 % (w/v) HS-β-CD 
7 x 10
-11 56 
 
LIF  
( em= 266 nm) 
FASS EKC Propranolol Standards 2 mM acetate (pH 2.5)  
+ 0.14 % (w/v) HS- -CD 
 
~ 2 x 10
-10
 
 
57 
Phosphorescence 
( exc= 465 nm) 
-- EKC Camphorquinone Standards 
25 mM borate (pH 9.0)  
+ 20 mM α-CD + 10 mM CM-β-CD 
 
(2-10)x 10
-7
 58 
Phosphorescence 
( exc= 266 nm) 
-- EKC Camphorquinone Cured dental resin 
25 mM borate (pH 9.0) + 10
-5
 M 2,6-NS  
+ 20 mM α-CD + 10 mM CM-β-CD 
(4-5) x 10
-8
 
59 
Phosphorescence 
( exc= 266 nm) 
-- EKC Bupropion Pharmaceuticals 
and urine 
25 mM phosphate (pH 3.0)  
+ 2 x 10
-4
 M biacetyl + 5 mM S- -CD  
2 x 10
-7
 60 
ECL LLE + FASS EKC Dioxopromethazine Human urine 25 mM tris-phosphate/40 mM borate (pH 2.5) 
+16.5 mM β-CD 
 
4 x 10
-6
 
 
61 
Conductivity 
(C
4
D) 
LLE MEKC Lactic acid, 
-hydroxybutyric acid, 
2-hydroxycaproic acid, 
2-hydroxyoctanoic acid, 
2-hydroxydecanoic acid, 
Asp, Glu 
Milk,  yogurt 10 mM Tris /4.4 mM maleic acid (pH 7.35)  
+ 0.03mM CTAB + 5 mM vancomycin  
~ (2-3) x 10
-6
 62 
Conductivity 
(C
4
D) 
tMCRB 2D-CE Phe, Thr Standards 2.3 M acetic acid (pH 2.1) for 1
st
 dimension 
and  2.3 M acetic acid (pH 2.1)  
+ 10 mM 18C6H4 for 2
nd
 dimension 
1-20) x 10
-7 63 
 
ESI-MS (Q) PFT EKC D-Ala-D-Ala, L-Ala-L-
Ala, DL-Leu-, DL-Leu, 
Gly-D-Phe, Gly-L-Phe 
Serum 2 M acetic acid (pH 2.15); 
PFT: 3 M acetic acid (pH 2.00)  
+ 5 mM 18C6H4  (50 mbar for 960 s) 
(5-20) x 10
-8
 64 
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ESI-MS
2
 (IT) PFT EKC N-methylsalsolinol, 
salsolinol, 1-benzyl- 
1,2,3,4-
tetrahydroisoquinoline 
In vitro study in an 
incubation solution 
20 mM ammonium acetate (pH 5.5);  
PFT: 20 mM acetic acid/ammonium acetate 
(pH 5.5) + 1 mM S-β-CD (100 mbar x 50) 
~ 1 x 10
-6
 65 
ESI-MS (TOF) FITC 
derivatization 
EKC Ala, Arg, Asn, Asp, Glu, 
 
Soy, vinegar 50 mM ammonium carbonate (pH 8.0) 
 + 0.5 mM CD3NH2 
(2-19) x 10
-7
 65 
ESI-MS
2
 (IT) FMOC-
derivatization 
EKC Carnitine Pharmaceuticals 0.5 M ammonium formate (pH 2.5)  
+ 0.2% Succ-γ-CD 
~ 6 x 10
-8
 67 
ICP-MS -- EKC Thyroxine Pharmaceuticals 10 mM borate (pH 9.6) + 10% acetonitrile  
+ Cu(II)/L-proline (0.05 mM/0.40 mM)  
~ 4 x 10
-7
 68 
 
2,6-NS, 2,6-naphthalenedisulfonic acid; Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartic acid; BrNS, 1-bromo-4-naphthalene sulfonic 
acid; CBI, cyanobenz[f]isoindole; C
4
D, contactless conductivity detection; CD3NH2, 3-monodeoxy-3-monoamino-β-CD; CM-β-CD, carboxymethyl-
β-CD; DM-β-CD, 2,6-O-Dimethyl-β-CD; DTAF, 5-(4,6-dichloro-s-triazin-2-ylamino)fluorescein; Glu, glutamic acid; Gly, glycine; HP-β-CD, 2-
hydroxypropyl-β-CD; HS- -CD: high sulphated- -CD HS-β-CD: high sulphated-β-CD; Ile, isoleucine; Leu, leucine; MeOH, methanol; NAD, 
naphthalene-2,3-dicarboxaldehyde; PEO, poly(ethylene oxide); Phe, phenylalanine; Poly-L-SUCIL, polysodium N-undecenoxycarbonyl-L-
isoleucinate; Q, quadrupole analyzer; S- -CD,  sulphated- -CD; S-β-CD,  sulphated-β-CD; SC, sodium cholate; Ser, serine; STC, sodium 
taurodeoxycholate; Succ-γ-CD, succinyl-γ-CD;  Thr, Threonine; Tris, tris(hydroxymethyl)aminomethane; Trp, tryptophan; Val, valine. 
 
 
  
 
